PeptideStack
5.2kquestions
20kanswers
220users
PM

pieter_maas

Member for 2.4 yearsMember since 2 Mar 2024Last seen 31 days agoFrom Tallinn, EE

I have made most of the reconstitution mistakes so you do not have to.

14kreputation
30answers
4accepted
22questions
0·1·7badges g·s·b
58tags

30 answers · 4 accepted · highest score 97

97Does hair thinning at week eight of survodutide usually resolve without a dose change?accepted · answered 24 Sept 2025 · hair-loss, titration, survodutide69Does aspartimide formation of oral semaglutide at room temperature show up as a loss of content or of purity?answered 22 Dec 2024 · peptide-stability, content-assay, purity56What did the placebo arm of SURMOUNT-OSA report for hair thinning?accepted · answered 11 Mar 2026 · clinical-trials, hair-loss56What is the thermal exposure on a Xi’an to Poland lane in summer?answered 22 Dec 2025 · cold-chain, international-shipping, storage47What did the placebo arm of SURMOUNT-5 report for injection-site erythema?answered 17 Aug 2024 · clinical-trials, injection-site-reaction47What is the reported incidence of hair thinning on oral semaglutide in PIONEER-1?answered 15 Sept 2024 · hair-loss, clinical-trials, oral-glp140Does cystatin C tell me anything about hepatic fat on survodutide?answered 8 Apr 2025 · liver-enzymes, mash, bloodwork39Is hair thinning on oral semaglutide dose-dependent or dose-rate dependent?accepted · answered 20 Jun 2026 · hair-loss, titration, oral-glp138Does hydrolysis dominate for orforglipron held at 25 °C?answered 13 Feb 2025 · peptide-stability, storage, hplc36Does vomiting at week nine of cagrilintide usually resolve without a dose change?answered 9 Jun 2026 · vomiting, titration, amylin36What does REDEFINE-1 tell me about injection-site erythema at the 2.4 mg dose?accepted · answered 19 Jun 2025 · clinical-trials, injection-site-reaction, titration35Is a rising lipase without symptoms actionable?answered 24 Feb 2026 · pancreatitis, bloodwork, harm-reduction35What did the placebo arm of STEP 1 report for hair thinning?answered 20 Oct 2024 · clinical-trials, hair-loss34What is the reported incidence of injection-site erythema on retatrutide in TRIUMPH-1?answered 7 Apr 2025 · injection-site-reaction, clinical-trials, retatrutide32Would you re-test oral semaglutide after three weeks at 40 °C, or accept the original certificate?answered 25 Oct 2025 · batch-testing, peptide-stability, coa31Does holding at 5 mg for six weeks before escalating reduce injection-site erythema?answered 7 Sept 2025 · titration, injection-site-reaction, dose-escalation27At what point does upper abdominal pain warrant urgent assessment?answered 3 Dec 2024 · pancreatitis, gi-side-effects, harm-reduction25Does site rotation actually have evidence behind it, and what kind of reaction warrants stopping?answered 14 Jul 2026 · injection-site-reaction, injection-technique, subcutaneous23What differentiates an injection-site nodule from an infection?answered 1 Jul 2025 · injection-site-reaction, subcutaneous, harm-reduction21Does holding at 0.5 mg for three weeks before escalating reduce injection-site erythema?answered 15 Feb 2026 · titration, injection-site-reaction, dose-escalation21What did the placebo arm of SURMOUNT-OSA report for injection-site erythema?answered 30 Jun 2024 · clinical-trials, injection-site-reaction18What did the placebo arm of ATTAIN-1 report for hair thinning?answered 13 Jan 2025 · clinical-trials, hair-loss18Why does racemisation accelerate at 40 °C rather than proceeding linearly?answered 4 Mar 2025 · peptide-stability, storage, hplc15What did the placebo arm of SURPASS-3 report for hair thinning?answered 28 Apr 2025 · clinical-trials, hair-loss14Does hair thinning at week six of dulaglutide usually resolve without a dose change?answered 29 Aug 2025 · hair-loss, titration, dulaglutide14Does holding at 5 mg for six weeks before escalating reduce injection-site erythema?answered 2 Nov 2025 · titration, injection-site-reaction, dose-escalation14What did the placebo arm of PIONEER-1 report for injection-site erythema?answered 28 Feb 2025 · clinical-trials, injection-site-reaction9Is lipase worth drawing at baseline before starting cagrilintide?answered 30 May 2026 · bloodwork, harm-reduction, a1c6What is the dead-space loss per draw with a 31G needle at 4 mg/mL?answered 11 Feb 2026 · dead-space, insulin-syringe, dosing-math3Is injection-site erythema on survodutide dose-dependent or dose-rate dependent?answered 4 Sept 2024 · injection-site-reaction, titration, survodutide